News & Events

Xentria's latest news and developments.
August 04, 2022
Xentria Announces Initial Findings Showing Novel Biologic XTMAB-16’s Potential to Reduce Sarcoidosis Granuloma

Early data presented support the evaluation of XTMAB-16 as a potential therapy for patients with sarcoidosis

Read more
June 23, 2022
Xentria to Present Initial Findings from Preclinical Study of XTMAB-16 at ATS 2022 International Conference

Findings Demonstrating Suppression of the Inflammatory Pathways Promoting Sarcoidosis Granuloma Formation to be Highlighted in Poster Presentation

Read more
March 08, 2022
December 06, 2021
Xentria Announces the Initiation of a Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis

Xentria Announces the Initiation of a Clinical Trial for XTMAB-16 for the Treatment of Sarcoidosis

Read more
June 22, 2021
NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business

NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business

Read more
May 20, 2021
March 03, 2021
Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

Read more
December 15, 2020
FSR Global Virtual Patient Summit
FSR Global Virtual Patient Summit
Date: Date: July 2022

Unveiling Possibilities brings connection, expertise, and shared experiences to help patients and loved ones throughout the sarcoidosis journey. FSR's Patient Summit is a two-day online opportunity for learning, community, and wellness. 

See event

American Thoracic Society (ATS) International Conference 2022
American Thoracic Society (ATS) International Conference 2022
Date: May 13-18, 2022

Xentria presents new data on XTMAB-16 with a poster presentation at the American Thoracic Society (ATS) International Conference 2022 in San Francisco, CA. 

See event

The Balancing Act Presents Behind the Mystery
The Balancing Act Presents Behind the Mystery
Date: December 2021

Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder. Segments highlight the emotional, scientific, and medical aspects associated with rare and genetic diseases. The goal is to expand awareness for rare and genetic diseases through partnerships with pharmaceutical and biotech companies, while giving voices to the patients, families, and advocates affected via our national television platform. December’s specialized segment will focus on sarcoidosis, a rare inflammatory disease that can affect almost any organ in the body.


See event

WASOG/AASOG 2021: Multidisciplinary Meeting for Sarcoidosis and ILD
WASOG/AASOG 2021: Multidisciplinary Meeting for Sarcoidosis and ILD
Date: November 29 - December 2 2021

Topics will focus on interstitial lung diseases (ILD) including sarcoidosis along with cutting-edge advances in parenchymal lung disease and cardiac sarcoidosis.

Join an interdisciplinary audience of practitioners and healthcare professionals who seek to learn the latest developments in sarcoidosis and interstitial lung disease. Learn more about this meeting at their website.

See event

13th Annual EveryLife Foundation Scientific Workshop
13th Annual EveryLife Foundation Scientific Workshop
Date: October 20th 2021

On Wednesday, October 20th, the EveryLife Foundation’s 13th Annual Rare Disease Scientific Workshop explores the “Current and Future Barriers to the Utilization of Accelerated Approval Pathway for Novel Rare Disease Therapies.” Through expert panels and real-world case study presentations, partners representing patient advocates, government agencies, pharmaceutical companies, and researchers identify the research, regulatory, and access policy barriers to increasing the utilization of the Accelerated Approval pathway for rare disease therapeutic development. Watch the event Livestream, HERE, on October 20th, and join the conversation on social media using #ScientificWorkshop2021.


See event

FSR’s Clinical Engagement Conference
FSR’s Clinical Engagement Conference
Date: October 2nd 2021

FSR is hosting their inaugural Clinical Engagement Conference which brings together members of the healthcare community for an opportunity to unite and discuss ways to best serve the sarcoidosis community.

The Foundation for Sarcoidosis Research (FSR) is the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and to improving care for sarcoidosis patients. Since its establishment in 2000, FSR has fostered over $5 million in sarcoidosis-specific research efforts and has worked diligently to provide resources to thousands.


See event

FSR Virtual Patient Education Summit
FSR Virtual Patient Education Summit
Date: June 2021

FSR’s Virtual Summit is a two-day online opportunity for learning, community, and wellness. These events allow patients living with sarcoidosis to connect with leading experts in both the clinical and research fields.


See event

Patient Focus Group
Patient Focus Group
Date: April 2021

Involving patients and collaborating with the community are the fundamental basics of patient-centered drug development. Xentria held a Patient Focus Group aimed to better understand the real-life needs of people who live with sarcoidosis by involving the patient experience and perspective.

See event

This website uses cookies

We use cookies to improve your experience on our site. You can read more about our Cookie Policy in our Privacy policy.

Allow cookies Reject cookies